Abstract
Purpose
The following study aimed to determine the existence of blood biomarkers in symptomatic patients with or without lumbar Modic changes (MC).
Methods
A cross-sectional sub-analyses of a prospective cohort was performed. Fasting blood samples were collected from patients with and without lumbar MC who had undergone spinal fusion or microdiscectomy. An 80-plex panel and CCL5/RANTES were used to assess preoperative plasma cytokine concentrations. Patient demographics and imaging phenotypes were also assessed.
Results
Thirty-one subjects were analysed (n = 18 no MC; n = 13 MC). No significant differences were found in age, sex, body mass index, smoking and alcohol history, and surgical procedure (i.e. fusion, decompression) between the two groups (p > 0.05). Several statistically significant blood biomarkers in MC patients were identified, including elevated levels of C–C Motif Chemokine Ligand 5 (CCL5, p = 0.0006), while Macrophage Migration Inhibitory Factor (MIF) was significantly lower (p = 0.009). Additionally, C-X-C Motif Chemokine Ligand 5 (CXCL5, p = 0.052), Pentraxin 3 (PTX3, p = 0.06) and Galectin-3 (Gal-3, p = 0.07) showed potential relevance. Moreover, MC patients exhibited significantly higher levels of disc degeneration (p = 0.0001) and displacement severity (p = 0.020). Based on multivariate analyses and controlling for disc degeneration/displacement, CCL5 (OR 1.02; 95% CI 1.002–1.033; p = 0.028) and MIF (OR 0.60; 95% CI 0.382–0.951; p = 0.030) were independently associated with MC patients.
Conclusion
This “proof-of-concept” study is the first to identify specific and significantly circulating blood biomarkers associated with symptomatic patients with lumbar MC, independent of disc alterations of degeneration and/or bulges/herniations. Specifically, differences in CCL5 and MIF protein levels were significantly noted in MC patients compared to those without MC.
Similar content being viewed by others
References
Vos T, Flaxman AD, Naghavi M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380(9859):2163–2196
Grabovac I, Dorner TE (2019) Association between low back pain and various everyday performances: activities of daily living, ability to work and sexual function. Wien Klin Wochenschr 131(21–22):541–549
Andersson GB (1999) Epidemiological features of chronic low-back pain. Lancet 354(9178):581–585
Fatoye F, Gebrye T, Mbada CE, Useh U (2023) Clinical and economic burden of low back pain in low-and middle-income countries: a systematic review. BMJ Open 13(4):e064119
Karppinen J, Shen FH, Luk KD, Andersson GB, Cheung KM, Samartzis D (2011) Management of degenerative disk disease and chronic low back pain. Orthop Clin North Am 42(4):513–28
Smith A, Hancock M, O’Hanlon S et al (2022) The association between different trajectories of low back pain and degenerative imaging findings in young adult participants within the raine study. Spine 47(3):269–76
Wong AYL, Karppinen J, Samartzis D (2017) Low back pain in older adults: risk factors, management options and future directions. Scoliosis Spinal Disord 12:14
Lotz J, Fields A, Liebenberg E (2013) The role of the vertebral end plate in low back pain. Glob Spine J 3(3):153–163
Mallow GM, Zepeda D, Kuzel TG et al (2022) ISSLS PRIZE in clinical science 2022: epidemiology, risk factors and clinical impact of juvenile Modic changes in paediatric patients with low back pain. Eur Spine J 31(5):1069–1079
Samartzis D, Mok FPS, Karppinen J, Fong DYT, Luk KDK, Cheung KMC (2016) Classification of Schmorl’s nodes of the lumbar spine and association with disc degeneration: a large-scale population-based MRI study. Osteoarthr Cartil 24(10):1753–1760
Teraguchi M, Hashizume H, Oka H et al (2022) Detailed subphenotyping of lumbar Modic changes and their association with low back pain in a large population-based study: the wakayama spine study. Pain Ther 11(1):57–71
Mallow GM, Zepeda D, Kuzel TG et al (2022) ISSLS PRIZE in clinical science 2022: epidemiology, risk factors and clinical impact of juvenile Modic changes in paediatric patients with low back pain. Eur Spine J 31(5):1069–1079
Albert HB, Kjaer P, Jensen TS, Sorensen JS, Bendix T, Manniche C (2008) Modic changes, possible causes and relation to low back pain. Med Hypotheses 70(2):361–368
Jensen RK, Leboeuf-Yde C, Wedderkopp N, Sorensen JS, Jensen TS, Manniche C (2012) Is the development of Modic changes associated with clinical symptoms? A 14-month cohort study with MRI. Eur Spine J 21:2271–2279
Jensen TS, Karppinen J, Sorensen JS, Niinimäki J, Leboeuf-Yde C (2008) Vertebral endplate signal changes (Modic change): a systematic literature review of prevalence and association with non-specific low back pain. Eur Spine J 17:1407–1422
Karppinen J, Solovieva S, Luoma K, Raininko R, Leino-Arjas P, Riihimäki H (2009) Modic changes and interleukin 1 gene locus polymorphisms in occupational cohort of middle-aged men. Eur Spine J 18:1963–1970
Herger N, Bermudez-Lekerika P, Farshad M et al (2022) Should degenerated intervertebral discs of patients with Modic type 1 changes be treated with mesenchymal stem cells? Int J Mol Sci 23(5):2721
Modic MT, Masaryk TJ, Ross JS, Carter JR (1988) Imaging of degenerative disk disease. Radiology 168(1):177–186
Georgy M, Stern M, Murphy K (2017) What is the role of the bacterium propionibacterium acnes in type 1 Modic changes? A review of the literature. Can Assoc Radiol J 68(4):419–424
Dudli S, Ballatori A, Bay-Jensen A-C et al (2020) Serum biomarkers for connective tissue and basement membrane remodeling are associated with vertebral endplate bone marrow lesions as seen on MRI (Modic changes). Int J Mol Sci 21(11):3791
Grad S, Bow C, Karppinen J et al (2016) Systemic blood plasma CCL5 and CXCL6: potential biomarkers for human lumbar disc degeneration. Eur Cell Mater 31:1–10
Pedersen LM, Schistad E, Jacobsen LM, Røe C, Gjerstad J (2015) Serum levels of the pro-inflammatory interleukins 6 (IL-6) and-8 (IL-8) in patients with lumbar radicular pain due to disc herniation: a 12-month prospective study. Brain Behav Immun 46:132–136
Schistad EI, Espeland A, Pedersen LM, Sandvik L, Gjerstad J, Røe C (2014) Association between baseline IL-6 and 1-year recovery in lumbar radicular pain. Eur J Pain 18(10):1394–1401
Dudli S, Fields AJ, Samartzis D, Karppinen J, Lotz JC (2016) Pathobiology of Modic changes. Eur Spine J 25(11):3723–3734
Karppinen J, Koivisto K, Ketola J et al (2021) Serum biomarkers for Modic changes in patients with chronic low back pain. Eur Spine J 30:1018–1027
Määttä JH, Karppinen J, Paananen M, et al. (2016) Refined phenotyping of Modic changes. Medicine 95(22).
Mok FPS, Samartzis D, Karppinen J, Fong DYT, Luk KDK, Cheung KMC (2016) Modic changes of the lumbar spine: prevalence, risk factors, and association with disc degeneration and low back pain in a large-scale population-based cohort. Spine J 16(1):32–41
Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N (2001) Magnetic resonance classification of lumbar intervertebral disc degeneration. spine 26(17):1873–8
Modic MT, Steinberg P, Ross J, Masaryk T, Carter J (1988) Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology 166(1):193–199
Knights D, Kuczynski J, Charlson ES et al (2011) Bayesian community-wide culture-independent microbial source tracking. Nat Methods 8(9):761–763
Zhang Y-H, Zhao C-Q, Jiang L-S, Chen X-D, Dai L-Y (2008) Modic changes: a systematic review of the literature. Eur Spine J 17(10):1289–1299
Yang Y, Hou J, Shao M et al (2017) CXCL5 as an autocrine or paracrine cytokine is associated with proliferation and migration of hepatoblastoma HepG2 cells. Oncol Lett 14(6):7977–7985
Grieb G, Merk M, Bernhagen J, Bucala R (2010) Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 23(4):257
Liu W, Liu D, Zheng J et al (2017) Annulus fibrosus cells express and utilize CC chemokine receptor 5 (CCR5) for migration. Spine J 17(5):720–726
Garlanda C, Bottazzi B, Magrini E, Inforzato A, Mantovani A. (2018) PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer. Physiological reviews.
Hara A, Niwa M, Noguchi K et al (2020) Galectin-3 as a next-generation biomarker for detecting early stage of various diseases. Biomolecules 10(3):389
Marques RE, Guabiraba R, Russo RC, Teixeira MM (2013) Targeting CCL5 in inflammation. Expert Opin Ther Targets 17(12):1439–1460
Shea GK, Zhang C, Suen WS et al (2022) Oral zoledronic acid bisphosphonate for the treatment of chronic low back pain with associated Modic changes: a pilot randomized controlled trial. J Orthop Res® 40(12):2924–36
Freidin M, Kraatari M, Skarp S et al (2019) Genome-wide meta-analysis identifies genetic locus on chromosome 9 associated with Modic changes. J Med Genet 56(7):420–426
Karppinen J, Daavittila I, Solovieva S et al (2008) Genetic factors are associated with Modic changes in endplates of lumbar vertebral bodies. Spine 33(11):1236–1241
Wong AY, Mallow GM, Pinto SM et al (2023) The efficacy and safety of oral antibiotic treatment in patients with chronic low back pain and Modic changes: a systematic review and meta-analysis. JOR Spine 7(1):e1281
Li Y, Karppinen J, Cheah KS, Chan D, Sham PC, Samartzis D. (2021) Integrative analysis of metabolomic, genomic, and imaging-based phenotypes identify very-low-density lipoprotein as a potential risk factor for lumbar Modic changes. Eur Spine J 1–11.
Samartzis D, Alini M, An HS, et al. (2018) Precision spine care: a new era of discovery, innovation, and global impact. SAGE Publications Sage CA: Los Angeles, CA 321–2
Pulsatelli L, Dolzani P, Piacentini A et al (1999) Chemokine production by human chondrocytes. J Rheumatol 26(9):1992–2001
Pattappa G, Peroglio M, Sakai D et al (2014) CCL5/RANTES is a key chemoattractant released by degenerative intervertebral discs in organ culture. Eur Cells Mater eCM 27:124–136
Rannou F, Ouanes W, Boutron I et al (2007) High-sensitivity C-reactive protein in chronic low back pain with vertebral end-plate Modic signal changes. Arthritis Care Res 57(7):1311–1315
Burke J, Watson R, McCormack D, Dowling F, Walsh M, Fitzpatrick J (2002) Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg British 84(2):196–201
Sowa GA, Perera S, Bechara B et al (2014) Associations between serum biomarkers and pain and pain-related function in older adults with low back pain: a pilot study. J Am Geriatr Soc 62(11):2047–2055
Funding
National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant # R21AR079679; Thomas J. Coogan Sr. MD Endowment.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
Authors have no financial or conflicting interests to disclose in relation to this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Aboushaala, K., Chee, A.V., Toro, S.J. et al. Discovery of circulating blood biomarkers in patients with and without Modic changes of the lumbar spine: a preliminary analysis. Eur Spine J 33, 1398–1406 (2024). https://doi.org/10.1007/s00586-024-08192-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-024-08192-y